Skip to main content

Table 4 Comparison of frequently used STOPPFrail-PIM by sex, age, and living condition

From: Prevalence of potentially inappropriate medications based on the STOPPFrail criteria in frail older patients with limited life expectancy: a cross-sectional study

STOPPFrail Criteria Section Sex Age Living Condition
Female
(n = 92)
Male
(n = 79)
p-value  < 85 years
(n = 105)
 ≥ 85 years
(n = 66)
p-value Nursing home
(n = 69)
Long-term care hospital
(n = 102)
p-value
n % n n n % n % n % n %
A2 Any drug without clear clinical indication 65 70.6 65 82.3 0.76 82 78.1 48 72.7 0.423 50 72.5 80 78.4 0.37
B1 Lipid lowering therapies 32 34.8 30 38.0 0.665 40 38.1 22 33.3 0.528 34 49.3 28 27.5 0.004
D1 Neuroleptic antipsychotics 22 23.9 19 24.1 0.983 25 23.8 16 24.2 0.949 18 26.1 23 22.5 0.595
C1 Antiplatelet for primary prevention 19 20.7 18 22.8 0.736 23 21.9 14 21.2 0.915 22 31.9 15 14.7 0.007
I1 Diabetic oral agents for stringent control 11 12.0 14 17.7 0.453 19 18.1 6 9.1 0.105 9 13.0 16 15.7 0.631
G1 Calcium supplementation 14 15.2 7 8.9 0.207 13 12.4 8 12.1 0.960 9 13.0 12 11.8 0.803
D2 Memantine without BPSD 10 10.9 11 14.0 0.544 13 12.4 8 12.1 0.960 12 17.4 9 8.8 0.094
J1 Multivitamins 7 7.6 6 8.0 0.287 9 8.6 4 6.1 0.105 0 0 13 12.7 -
E2 High-dose H2RA (full therapeutic dose with ≥ 8 weeks) 8 8.7 5 6.3 0.560 8 7.6 5 7.6 0.992 2 2.9 11 10.8 0.056
G4 Long-term oral NSAIDs (≥ 2 months) 7 7.6 6 7.6 0.991 8 7.6 5 7.6 0.992 10 14.5 3 2.9 0.005
  1. STOPPFrail-PIM potentially inappropriate medication according to STOPPFrail (Screening Tool of Older Persons’ Prescriptions in Frail adults with a limited life expectancy) criteria
  2. H2RA H2 receptor antagonist, NSAID non-steroidal anti-inflammatory drug, PPI proton pump inhibitor